Stocks (^DJI, ^GSPC, ^IXIC) hover here near all-time highs despite worry around the globe, including a big day coming up in Washington. Plus, Apple’s big WWDC just wrapped up. We have all the major product and software details. And, Amazon’s been on fire this year, but does the company have yet another ace up its sleeve? We explain. Catch The Final Round at 4 p.m. with Andy Serwer and Yahoo Finance markets correspondent Myles Udland.
Winners and losers
Stocks in the red today include Juno Therapeutics following a patient death in a cancer drug trial; Mallinckrodt on a Citron Research note critical of one of the drugmaker’s high-priced treatments; and Herbalife, with shares slipping after the supplements company said it expects sales to drop more than 6%, as it starts following new FTC rules.
Stocks in the green today include Gigamon as Reuters reports the network software company is looking to explore a sale; Loxo Oncology on the back of strong cancer drug trial results; and Forestar Group, with shares of the residential land developer jumping after D. R. Horton submitted a bid do buy 75% of the company, a superior bid to an existing offer submitted by Starwood Capital.
- At 10 a.m. ET, we’ll get another look at the employment situation with the JOLTS report for April. The prior month saw nearly 5.7 million job openings.
- And we’ve got more earnings on tap with Michaels and Canadian Solar before the bell, plus Dave and Buster’s after the close.
- Finally the Financial CHOICE Act—the bill that would repeal much of Dodd-Frank—heads to the House Rules Committee before it goes to the floor for a vote later this week.